Obsah

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

Autor: Zenz, Thorsten, Häbe, Sonja, Denzel, Tina, Mohr, Julia, Winkler, Dirk, Bühler, Andreas, Sarno, Antonio, Groner, Silja, Mertens, Daniel, Busch, Raymonde, Hallek, Michael, Döhner, Hartmut, Stilgenbauer, Stephan
Zdroj: In Blood 24 September 2009 114(13):2589-2597
Databáze: ScienceDirect
Pro tento záznam nejsou dostupné žádné jednotky.